- Mar 15
- 3 min
Resoundant Applauds FDA Approval of Resmetirom: A Milestone for MASLD and MASH Patients
Rochester, MN – Resoundant, a Mayo Clinic company and the developer of Magnetic Resonance Elastography (MRE), is thrilled to announce the...
- Jan 22
- 7 min
Study: Utility and impact of magnetic resonance elastography in the clinical course and management of chronic liver disease
Colin Feuille, Swathi Kari, Roshan Patel, Rohan Oberoi, Jonathan Liu, Michael Ohliger, Mandana Khalili & Michele Tana Scientific Reports...
- Jun 27, 2023
- 2 min
Renaming NAFLD: The Importance and Implications of the Transition to MASLD
The lexicon of medicine is often filled with complex jargon, reflecting the intricacies of human health. Occasionally, these medical...
- May 31, 2023
- 1 min
Available Now - Resoundant Spring Newsletter
Get caught up on all-things-MRE with our spring newsletter. Read more here: https://www.resoundant.com/so/f7OVT2W4C?languageTag=en
- Apr 11, 2023
- 2 min
Resoundant Appoints Joel Felmlee, PhD, as Chief Operating Officer
Rochester, MN, USA—Resoundant, Inc. is excited to announce the appointment of Joel Felmlee, PhD as the new Chief Operating Officer (COO)....